Quick Takeaways
- Orca Capital AG filed SCHEDULE 13G/A for Co-Diagnostics, Inc. Common Stock, par value $0.001 per share (CODX).
- Disclosed ownership: 3.7%.
- Date of event: 28 Oct 2025.
Orca Capital AG - 28 Oct 2025 SCHEDULE 13G/A Report for Co-Diagnostics, Inc. Common Stock, par value $0.001 per share (CODX)
- Filing Manager
- Orca Capital AG
- Reporting Manager
- Orca Capital AG
- Symbol
- CODX
- Shares outstanding
- 60,761,676 shares
- Disclosed Ownership
- 2,248,182 shares
- Ownership
- 3.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Oct 2025, 16:07:18 UTC
- Date of event
- 28 Oct 2025
- Previous filing
- 19 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Orca Capital AG disclosed 3.7% ownership in Co-Diagnostics, Inc. Common Stock, par value $0.001 per share (CODX) on 28 Oct 2025."
What Changed
- Previous schedule filing date: 19 Sep 2025.
- Current filing was accepted on 30 Oct 2025, 16:07.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Orca Capital AG | 3.7% | 2,248,182 | 2,248,182 | 0 | /s/ Thomas Konig | Thomas Konig/Director |